Ireland· IE-PA-EU/1/22/1656/001-002
Ertapenem SUN 1 g powder for concentrate for solution for infusion
A ertapenem product containing ertapenem sodium, registered in Ireland by Sun Pharmaceutical Industries Europe B.V.. The same ATC class is registered in 16 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Ertapenem is registered in 16 of 19 countries.
Countries holding a registration under ATC J01DH03 (ertapenem), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 9 of them publish a price we can compare per daily dose
Ertapenem · ATC J01DH03
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ertapenem costs, country by country.
Normalised to the WHO defined daily dose (1 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ertapenem · price per daily dose (1 g)
USD · FX 28 Sept 2026
- CH Switzerland$74.64
The record
At a glance
HPRA (Ireland)- Active substance
- Ertapenem sodium
- Manufacturer
- Sun Pharmaceutical Industries Europe B.V.
- Country
- Ireland (IE)
- ATC code
- J01DH03
- ATC class
- Ertapenem
- Defined daily dose
- 1 g, P
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/22/1656/001-002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
56 interactions on record for ertapenem.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ertapenem · interactions on record
56 records
- 4 severe
- 13 moderate
- 38 info
Most severe, free to view
- BupropionN06AX12severe
- BupropionN07BA02severe
- IohexolV08AB02severe
- IopamidolV08AB04severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ertapenem in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainERTAPENEM AUROVITAS 1 G POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFGEugia Pharma (Malta) Limited
- FinlandErtapenem AptaPharmaApta Medica Internacional d.o.o.
- CzechiaERTAPENEM APTAPHARMAApta Medica Internacional d.o.o., Ljubljana
- SwedenErtapenem AptaPharma 1 g Pulver till koncentrat till infusionsvätska, lösningAPTA MEDICA INTERNACIONAL
- PolandErtapenem AptaPharmaApta Medica Internacional d.o.o.
- NorwayErtapenem QiluQILU PHARMA SPAIN S.L.
- IcelandErtapenem SUNSun Pharmaceutical Industries Europe B.V.
- BelgiumErtapenem Sun 1 gSun Pharmaceutical Industries Europe
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Ertapenem Aptapharma, Ertapenem Fresenius Kabi
- Bulgaria · Ертапенем Аптафарма
- Cyprus · Ertapenem Aptapharma
- Czechia · Ertapenem Aptapharma, Ertapenem Ash
- Germany · Ertapenem Steriscience
- Denmark · Ertapenem "aptapharma", Ertapenem Fresenius Kabi
- Estonia · Ertapenem Fresenius Kabi, Ertapenem Qilu
- Spain · Ertapenem, Ertapenem Aurovitas
- Finland · Ertapenem Aptapharma, Ertapenem Fresenius Kabi
- France · Ertapenem Acs Dobfar, Ertapenem Arrow
- United Kingdom (Northern Ireland) · Ertapenem Acs Dobfar, Ertapenem Aspire Pharma
- Greece · Ertapenem Anfarm
- Croatia · Ertapenem Aptapharma, Ertapenem Fresenius Kabi
- Hungary · Ertapenem Anfarm, Ertapenem Aptapharma
- Iceland · Invanz
- Italy · Ertapenem Acs Dobfar, Ertapenem Aurobindo
- Liechtenstein · Invanz
- Lithuania · Ertapenem Qilu
- Latvia · Ertapenem Qilu
- Malta · Ertapenem Aptapharma
- Netherlands · Ertapenem Added Pharma, Ertapenem Aptapharma
- Norway · Ertapenem Aptapharma, Ertapenem Fresenius Kabi
- Poland · Ertapenem Aptapharma, Ertapenem Eugia
- Portugal · Ertapenem, Ertapenem Aurovitas
- Romania · Ertapenem Acs Dobfar, Ertapenem Aptapharma
- Sweden · Ertapenem Aptapharma, Ertapenem Fresenius Kabi
- Slovenia · Ertapenem Aptapharma, Ertapenem Fresenius Kabi
- Slovakia · Ertapenem Aptapharma, Ertapenem Ash
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/91abb3b8-7518-4de6-8077-28202ced6f81 GET /v1/drugs/91abb3b8-7518-4de6-8077-28202ced6f81?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for concentrate for solution for infusion",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"J01DH03"
],
"strength": null,
"pa_number": "EU/1/22/1656/001-002",
"substances": [
"Ertapenem sodium"
],
"legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "15/07/2022",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about ertapenem.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.